HopeAI

About:

AI-powered clinical evidence for drug development and precision medicine

Website: https://hopeai.co

Top Investors: Plug and Play, Taihill Venture, PKSHA Capital

Description:

At HopeAI, we are on a mission to bring hope to patients by accelerating the clinical development of new treatments through AI. Patients cannot wait. We believe AI-enabled clinical trials are the key to bringing life-saving medicines to patients faster and more efficiently. Our initial approach involves crafting an AI copilot with up-to-date clinical evidence and profound statistical insights. This AI copilot will work alongside the clinical development team to make swift and data-optimized decisions throughout trial design and execution, enhancing probability of success and expediting time to market. As AI continues to advance, we envision a future where all promising drug candidates can be rapidly tested in AI-enabled clinical trials and made accessible to patients in need. We are committed to paving the 'highway' for clinical trials.

Total Funding Amount:

$1.1M

Headquarters Location:

Princeton, New Jersey, United States

Founded Date:

2023-10-09

Contact Email:

info(AT)hopeai.co

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-01-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai